- Home
- CISS vs EVGN Comparison
CISS vs EVGN Comparison
Compare CISS & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CISS
- EVGN
- Stock Information
- Founded
- CISS 2022
- EVGN 1999
- Country
- CISS Greece
- EVGN Israel
- Employees
- CISS N/A
- EVGN N/A
- Industry
- CISS Marine Transportation
- EVGN Agricultural Chemicals
- Sector
- CISS Consumer Discretionary
- EVGN Industrials
- Exchange
- CISS Nasdaq
- EVGN Nasdaq
- Market Cap
- CISS 11.9M
- EVGN 9.7M
- IPO Year
- CISS N/A
- EVGN N/A
- Fundamental
- Price
- CISS $1.09
- EVGN $1.74
- Analyst Decision
- CISS
- EVGN Strong Buy
- Analyst Count
- CISS 0
- EVGN 1
- Target Price
- CISS N/A
- EVGN $12.00
- AVG Volume (30 Days)
- CISS 110.7K
- EVGN 791.7K
- Earning Date
- CISS 11-19-2024
- EVGN 11-21-2024
- Dividend Yield
- CISS N/A
- EVGN N/A
- EPS Growth
- CISS N/A
- EVGN N/A
- EPS
- CISS N/A
- EVGN N/A
- Revenue
- CISS $47,503,090.00
- EVGN $9,449,000.00
- Revenue This Year
- CISS N/A
- EVGN $173.12
- Revenue Next Year
- CISS N/A
- EVGN $33.10
- P/E Ratio
- CISS N/A
- EVGN N/A
- Revenue Growth
- CISS 264.29
- EVGN 290.29
- 52 Week Low
- CISS $1.08
- EVGN $1.70
- 52 Week High
- CISS $68.50
- EVGN $10.40
- Technical
- Relative Strength Index (RSI)
- CISS 38.87
- EVGN 31.72
- Support Level
- CISS $1.13
- EVGN $1.70
- Resistance Level
- CISS $1.17
- EVGN $2.10
- Average True Range (ATR)
- CISS 0.05
- EVGN 0.21
- MACD
- CISS -0.01
- EVGN -0.01
- Stochastic Oscillator
- CISS 6.67
- EVGN 4.27
About CISS C3is Inc.
C3is Inc is a provider of international seaborne transportation services to dry bulk charterers, including major national and private industrial users, commodity producers and traders. The company owns and operates a fleet of two dry bulk carriers that transport major bulks such as iron ore, coal and grains, and minor bulks such as bauxite, phosphate and fertilizers. The total cargo-carrying capacity of our fleet is approximately 64,000 dwt.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment followed by Industry.